img

Global Tuberculosis Vaccine Drug Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Tuberculosis Vaccine Drug Market Insights, Forecast to 2034

Global Tuberculosis Vaccine Drug market is expected to reach to US$ million in 2024, with a positive growth of %, compared with US$ million in 2022. Backed with the increasing demand from downstream industries, Tuberculosis Vaccine Drug industry is evaluated to reach US$ million in 2029. The CAGR will be % during 2024 to 2029.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers
This report presents an overview of global Tuberculosis Vaccine Drug market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Tuberculosis Vaccine Drug market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Merck
Japan BCG Lab
Serum Institute of India
AJ Vaccines
BioFarma
GreenSignal Bio Pharma
China National Biotec
Biomed Lublin
Taj Pharmaceuticals
Ataulpho de Paiva
IVAC
Queen Saovabha Mem. Inst
Microgen
Segment by Type
Immune Vaccine
Therapy Vaccine

Segment by Application


Self-Procurement
UNICEF
Other

Segment by Region


US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Tuberculosis Vaccine Drug plant distribution, commercial date of Tuberculosis Vaccine Drug, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Tuberculosis Vaccine Drug introduction, etc. Tuberculosis Vaccine Drug Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports’s Conclusions of Tuberculosis Vaccine Drug
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Study Coverage
1.1 Tuberculosis Vaccine Drug Product Introduction
1.2 Market by Type
1.2.1 Global Tuberculosis Vaccine Drug Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Immune Vaccine
1.2.3 Therapy Vaccine
1.3 Market by Application
1.3.1 Global Tuberculosis Vaccine Drug Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Self-Procurement
1.3.3 UNICEF
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Tuberculosis Vaccine Drug Sales Estimates and Forecasts 2018-2029
2.2 Global Tuberculosis Vaccine Drug Revenue by Region
2.2.1 Global Tuberculosis Vaccine Drug Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Tuberculosis Vaccine Drug Revenue by Region (2018-2024)
2.2.3 Global Tuberculosis Vaccine Drug Revenue by Region (2024-2029)
2.2.4 Global Tuberculosis Vaccine Drug Revenue Market Share by Region (2018-2029)
2.3 Global Tuberculosis Vaccine Drug Sales Estimates and Forecasts 2018-2029
2.4 Global Tuberculosis Vaccine Drug Sales by Region
2.4.1 Global Tuberculosis Vaccine Drug Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Tuberculosis Vaccine Drug Sales by Region (2018-2024)
2.4.3 Global Tuberculosis Vaccine Drug Sales by Region (2024-2029)
2.4.4 Global Tuberculosis Vaccine Drug Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Tuberculosis Vaccine Drug Sales by Manufacturers
3.1.1 Global Tuberculosis Vaccine Drug Sales by Manufacturers (2018-2024)
3.1.2 Global Tuberculosis Vaccine Drug Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Tuberculosis Vaccine Drug in 2022
3.2 Global Tuberculosis Vaccine Drug Revenue by Manufacturers
3.2.1 Global Tuberculosis Vaccine Drug Revenue by Manufacturers (2018-2024)
3.2.2 Global Tuberculosis Vaccine Drug Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Tuberculosis Vaccine Drug Revenue in 2022
3.3 Global Key Players of Tuberculosis Vaccine Drug, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Tuberculosis Vaccine Drug Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Tuberculosis Vaccine Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Tuberculosis Vaccine Drug, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Tuberculosis Vaccine Drug, Product Offered and Application
3.8 Global Key Manufacturers of Tuberculosis Vaccine Drug, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Tuberculosis Vaccine Drug Sales by Type
4.1.1 Global Tuberculosis Vaccine Drug Historical Sales by Type (2018-2024)
4.1.2 Global Tuberculosis Vaccine Drug Forecasted Sales by Type (2024-2029)
4.1.3 Global Tuberculosis Vaccine Drug Sales Market Share by Type (2018-2029)
4.2 Global Tuberculosis Vaccine Drug Revenue by Type
4.2.1 Global Tuberculosis Vaccine Drug Historical Revenue by Type (2018-2024)
4.2.2 Global Tuberculosis Vaccine Drug Forecasted Revenue by Type (2024-2029)
4.2.3 Global Tuberculosis Vaccine Drug Revenue Market Share by Type (2018-2029)
4.3 Global Tuberculosis Vaccine Drug Price by Type
4.3.1 Global Tuberculosis Vaccine Drug Price by Type (2018-2024)
4.3.2 Global Tuberculosis Vaccine Drug Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Tuberculosis Vaccine Drug Sales by Application
5.1.1 Global Tuberculosis Vaccine Drug Historical Sales by Application (2018-2024)
5.1.2 Global Tuberculosis Vaccine Drug Forecasted Sales by Application (2024-2029)
5.1.3 Global Tuberculosis Vaccine Drug Sales Market Share by Application (2018-2029)
5.2 Global Tuberculosis Vaccine Drug Revenue by Application
5.2.1 Global Tuberculosis Vaccine Drug Historical Revenue by Application (2018-2024)
5.2.2 Global Tuberculosis Vaccine Drug Forecasted Revenue by Application (2024-2029)
5.2.3 Global Tuberculosis Vaccine Drug Revenue Market Share by Application (2018-2029)
5.3 Global Tuberculosis Vaccine Drug Price by Application
5.3.1 Global Tuberculosis Vaccine Drug Price by Application (2018-2024)
5.3.2 Global Tuberculosis Vaccine Drug Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Tuberculosis Vaccine Drug Market Size by Type
6.1.1 US & Canada Tuberculosis Vaccine Drug Sales by Type (2018-2029)
6.1.2 US & Canada Tuberculosis Vaccine Drug Revenue by Type (2018-2029)
6.2 US & Canada Tuberculosis Vaccine Drug Market Size by Application
6.2.1 US & Canada Tuberculosis Vaccine Drug Sales by Application (2018-2029)
6.2.2 US & Canada Tuberculosis Vaccine Drug Revenue by Application (2018-2029)
6.3 US & Canada Tuberculosis Vaccine Drug Market Size by Country
6.3.1 US & Canada Tuberculosis Vaccine Drug Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Tuberculosis Vaccine Drug Sales by Country (2018-2029)
6.3.3 US & Canada Tuberculosis Vaccine Drug Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Tuberculosis Vaccine Drug Market Size by Type
7.1.1 Europe Tuberculosis Vaccine Drug Sales by Type (2018-2029)
7.1.2 Europe Tuberculosis Vaccine Drug Revenue by Type (2018-2029)
7.2 Europe Tuberculosis Vaccine Drug Market Size by Application
7.2.1 Europe Tuberculosis Vaccine Drug Sales by Application (2018-2029)
7.2.2 Europe Tuberculosis Vaccine Drug Revenue by Application (2018-2029)
7.3 Europe Tuberculosis Vaccine Drug Market Size by Country
7.3.1 Europe Tuberculosis Vaccine Drug Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Tuberculosis Vaccine Drug Sales by Country (2018-2029)
7.3.3 Europe Tuberculosis Vaccine Drug Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Tuberculosis Vaccine Drug Market Size
8.1.1 China Tuberculosis Vaccine Drug Sales (2018-2029)
8.1.2 China Tuberculosis Vaccine Drug Revenue (2018-2029)
8.2 China Tuberculosis Vaccine Drug Market Size by Application
8.2.1 China Tuberculosis Vaccine Drug Sales by Application (2018-2029)
8.2.2 China Tuberculosis Vaccine Drug Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Tuberculosis Vaccine Drug Market Size by Type
9.1.1 Asia Tuberculosis Vaccine Drug Sales by Type (2018-2029)
9.1.2 Asia Tuberculosis Vaccine Drug Revenue by Type (2018-2029)
9.2 Asia Tuberculosis Vaccine Drug Market Size by Application
9.2.1 Asia Tuberculosis Vaccine Drug Sales by Application (2018-2029)
9.2.2 Asia Tuberculosis Vaccine Drug Revenue by Application (2018-2029)
9.3 Asia Tuberculosis Vaccine Drug Sales by Region
9.3.1 Asia Tuberculosis Vaccine Drug Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Tuberculosis Vaccine Drug Revenue by Region (2018-2029)
9.3.3 Asia Tuberculosis Vaccine Drug Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Tuberculosis Vaccine Drug Market Size by Type
10.1.1 Middle East, Africa and Latin America Tuberculosis Vaccine Drug Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Tuberculosis Vaccine Drug Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Tuberculosis Vaccine Drug Market Size by Application
10.2.1 Middle East, Africa and Latin America Tuberculosis Vaccine Drug Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Tuberculosis Vaccine Drug Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Tuberculosis Vaccine Drug Sales by Country
10.3.1 Middle East, Africa and Latin America Tuberculosis Vaccine Drug Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Tuberculosis Vaccine Drug Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Tuberculosis Vaccine Drug Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Merck
11.1.1 Merck Company Information
11.1.2 Merck Overview
11.1.3 Merck Tuberculosis Vaccine Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 Merck Tuberculosis Vaccine Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Merck Recent Developments
11.2 Japan BCG Lab
11.2.1 Japan BCG Lab Company Information
11.2.2 Japan BCG Lab Overview
11.2.3 Japan BCG Lab Tuberculosis Vaccine Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 Japan BCG Lab Tuberculosis Vaccine Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Japan BCG Lab Recent Developments
11.3 Serum Institute of India
11.3.1 Serum Institute of India Company Information
11.3.2 Serum Institute of India Overview
11.3.3 Serum Institute of India Tuberculosis Vaccine Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 Serum Institute of India Tuberculosis Vaccine Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Serum Institute of India Recent Developments
11.4 AJ Vaccines
11.4.1 AJ Vaccines Company Information
11.4.2 AJ Vaccines Overview
11.4.3 AJ Vaccines Tuberculosis Vaccine Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 AJ Vaccines Tuberculosis Vaccine Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 AJ Vaccines Recent Developments
11.5 BioFarma
11.5.1 BioFarma Company Information
11.5.2 BioFarma Overview
11.5.3 BioFarma Tuberculosis Vaccine Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.5.4 BioFarma Tuberculosis Vaccine Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 BioFarma Recent Developments
11.6 GreenSignal Bio Pharma
11.6.1 GreenSignal Bio Pharma Company Information
11.6.2 GreenSignal Bio Pharma Overview
11.6.3 GreenSignal Bio Pharma Tuberculosis Vaccine Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.6.4 GreenSignal Bio Pharma Tuberculosis Vaccine Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 GreenSignal Bio Pharma Recent Developments
11.7 China National Biotec
11.7.1 China National Biotec Company Information
11.7.2 China National Biotec Overview
11.7.3 China National Biotec Tuberculosis Vaccine Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.7.4 China National Biotec Tuberculosis Vaccine Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 China National Biotec Recent Developments
11.8 Biomed Lublin
11.8.1 Biomed Lublin Company Information
11.8.2 Biomed Lublin Overview
11.8.3 Biomed Lublin Tuberculosis Vaccine Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.8.4 Biomed Lublin Tuberculosis Vaccine Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Biomed Lublin Recent Developments
11.9 Taj Pharmaceuticals
11.9.1 Taj Pharmaceuticals Company Information
11.9.2 Taj Pharmaceuticals Overview
11.9.3 Taj Pharmaceuticals Tuberculosis Vaccine Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.9.4 Taj Pharmaceuticals Tuberculosis Vaccine Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Taj Pharmaceuticals Recent Developments
11.10 Ataulpho de Paiva
11.10.1 Ataulpho de Paiva Company Information
11.10.2 Ataulpho de Paiva Overview
11.10.3 Ataulpho de Paiva Tuberculosis Vaccine Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.10.4 Ataulpho de Paiva Tuberculosis Vaccine Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Ataulpho de Paiva Recent Developments
11.11 IVAC
11.11.1 IVAC Company Information
11.11.2 IVAC Overview
11.11.3 IVAC Tuberculosis Vaccine Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.11.4 IVAC Tuberculosis Vaccine Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 IVAC Recent Developments
11.12 Queen Saovabha Mem. Inst
11.12.1 Queen Saovabha Mem. Inst Company Information
11.12.2 Queen Saovabha Mem. Inst Overview
11.12.3 Queen Saovabha Mem. Inst Tuberculosis Vaccine Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.12.4 Queen Saovabha Mem. Inst Tuberculosis Vaccine Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Queen Saovabha Mem. Inst Recent Developments
11.13 Microgen
11.13.1 Microgen Company Information
11.13.2 Microgen Overview
11.13.3 Microgen Tuberculosis Vaccine Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.13.4 Microgen Tuberculosis Vaccine Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Microgen Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Tuberculosis Vaccine Drug Industry Chain Analysis
12.2 Tuberculosis Vaccine Drug Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Tuberculosis Vaccine Drug Production Mode & Process
12.4 Tuberculosis Vaccine Drug Sales and Marketing
12.4.1 Tuberculosis Vaccine Drug Sales Channels
12.4.2 Tuberculosis Vaccine Drug Distributors
12.5 Tuberculosis Vaccine Drug Customers
13 Market Dynamics
13.1 Tuberculosis Vaccine Drug Industry Trends
13.2 Tuberculosis Vaccine Drug Market Drivers
13.3 Tuberculosis Vaccine Drug Market Challenges
13.4 Tuberculosis Vaccine Drug Market Restraints
14 Key Findings in The Global Tuberculosis Vaccine Drug Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Tuberculosis Vaccine Drug Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Immune Vaccine
Table 3. Major Manufacturers of Therapy Vaccine
Table 4. Global Tuberculosis Vaccine Drug Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 5. Global Tuberculosis Vaccine Drug Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global Tuberculosis Vaccine Drug Revenue by Region (2018-2024) & (US$ Million)
Table 7. Global Tuberculosis Vaccine Drug Revenue by Region (2024-2029) & (US$ Million)
Table 8. Global Tuberculosis Vaccine Drug Revenue Market Share by Region (2018-2024)
Table 9. Global Tuberculosis Vaccine Drug Revenue Market Share by Region (2024-2029)
Table 10. Global Tuberculosis Vaccine Drug Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 11. Global Tuberculosis Vaccine Drug Sales by Region (2018-2024) & (K Units)
Table 12. Global Tuberculosis Vaccine Drug Sales by Region (2024-2029) & (K Units)
Table 13. Global Tuberculosis Vaccine Drug Sales Market Share by Region (2018-2024)
Table 14. Global Tuberculosis Vaccine Drug Sales Market Share by Region (2024-2029)
Table 15. Global Tuberculosis Vaccine Drug Sales by Manufacturers (2018-2024) & (K Units)
Table 16. Global Tuberculosis Vaccine Drug Sales Share by Manufacturers (2018-2024)
Table 17. Global Tuberculosis Vaccine Drug Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 18. Global Tuberculosis Vaccine Drug Revenue Share by Manufacturers (2018-2024)
Table 19. Global Key Players of Tuberculosis Vaccine Drug, Industry Ranking, 2021 VS 2022 VS 2024
Table 20. Tuberculosis Vaccine Drug Price by Manufacturers 2018-2024 (US$/Unit)
Table 21. Global Tuberculosis Vaccine Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Tuberculosis Vaccine Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tuberculosis Vaccine Drug as of 2022)
Table 23. Global Key Manufacturers of Tuberculosis Vaccine Drug, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of Tuberculosis Vaccine Drug, Product Offered and Application
Table 25. Global Key Manufacturers of Tuberculosis Vaccine Drug, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Tuberculosis Vaccine Drug Sales by Type (2018-2024) & (K Units)
Table 28. Global Tuberculosis Vaccine Drug Sales by Type (2024-2029) & (K Units)
Table 29. Global Tuberculosis Vaccine Drug Sales Share by Type (2018-2024)
Table 30. Global Tuberculosis Vaccine Drug Sales Share by Type (2024-2029)
Table 31. Global Tuberculosis Vaccine Drug Revenue by Type (2018-2024) & (US$ Million)
Table 32. Global Tuberculosis Vaccine Drug Revenue by Type (2024-2029) & (US$ Million)
Table 33. Global Tuberculosis Vaccine Drug Revenue Share by Type (2018-2024)
Table 34. Global Tuberculosis Vaccine Drug Revenue Share by Type (2024-2029)
Table 35. Tuberculosis Vaccine Drug Price by Type (2018-2024) & (US$/Unit)
Table 36. Global Tuberculosis Vaccine Drug Price Forecast by Type (2024-2029) & (US$/Unit)
Table 37. Global Tuberculosis Vaccine Drug Sales by Application (2018-2024) & (K Units)
Table 38. Global Tuberculosis Vaccine Drug Sales by Application (2024-2029) & (K Units)
Table 39. Global Tuberculosis Vaccine Drug Sales Share by Application (2018-2024)
Table 40. Global Tuberculosis Vaccine Drug Sales Share by Application (2024-2029)
Table 41. Global Tuberculosis Vaccine Drug Revenue by Application (2018-2024) & (US$ Million)
Table 42. Global Tuberculosis Vaccine Drug Revenue by Application (2024-2029) & (US$ Million)
Table 43. Global Tuberculosis Vaccine Drug Revenue Share by Application (2018-2024)
Table 44. Global Tuberculosis Vaccine Drug Revenue Share by Application (2024-2029)
Table 45. Tuberculosis Vaccine Drug Price by Application (2018-2024) & (US$/Unit)
Table 46. Global Tuberculosis Vaccine Drug Price Forecast by Application (2024-2029) & (US$/Unit)
Table 47. US & Canada Tuberculosis Vaccine Drug Sales by Type (2018-2024) & (K Units)
Table 48. US & Canada Tuberculosis Vaccine Drug Sales by Type (2024-2029) & (K Units)
Table 49. US & Canada Tuberculosis Vaccine Drug Revenue by Type (2018-2024) & (US$ Million)
Table 50. US & Canada Tuberculosis Vaccine Drug Revenue by Type (2024-2029) & (US$ Million)
Table 51. US & Canada Tuberculosis Vaccine Drug Sales by Application (2018-2024) & (K Units)
Table 52. US & Canada Tuberculosis Vaccine Drug Sales by Application (2024-2029) & (K Units)
Table 53. US & Canada Tuberculosis Vaccine Drug Revenue by Application (2018-2024) & (US$ Million)
Table 54. US & Canada Tuberculosis Vaccine Drug Revenue by Application (2024-2029) & (US$ Million)
Table 55. US & Canada Tuberculosis Vaccine Drug Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 56. US & Canada Tuberculosis Vaccine Drug Revenue by Country (2018-2024) & (US$ Million)
Table 57. US & Canada Tuberculosis Vaccine Drug Revenue by Country (2024-2029) & (US$ Million)
Table 58. US & Canada Tuberculosis Vaccine Drug Sales by Country (2018-2024) & (K Units)
Table 59. US & Canada Tuberculosis Vaccine Drug Sales by Country (2024-2029) & (K Units)
Table 60. Europe Tuberculosis Vaccine Drug Sales by Type (2018-2024) & (K Units)
Table 61. Europe Tuberculosis Vaccine Drug Sales by Type (2024-2029) & (K Units)
Table 62. Europe Tuberculosis Vaccine Drug Revenue by Type (2018-2024) & (US$ Million)
Table 63. Europe Tuberculosis Vaccine Drug Revenue by Type (2024-2029) & (US$ Million)
Table 64. Europe Tuberculosis Vaccine Drug Sales by Application (2018-2024) & (K Units)
Table 65. Europe Tuberculosis Vaccine Drug Sales by Application (2024-2029) & (K Units)
Table 66. Europe Tuberculosis Vaccine Drug Revenue by Application (2018-2024) & (US$ Million)
Table 67. Europe Tuberculosis Vaccine Drug Revenue by Application (2024-2029) & (US$ Million)
Table 68. Europe Tuberculosis Vaccine Drug Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 69. Europe Tuberculosis Vaccine Drug Revenue by Country (2018-2024) & (US$ Million)
Table 70. Europe Tuberculosis Vaccine Drug Revenue by Country (2024-2029) & (US$ Million)
Table 71. Europe Tuberculosis Vaccine Drug Sales by Country (2018-2024) & (K Units)
Table 72. Europe Tuberculosis Vaccine Drug Sales by Country (2024-2029) & (K Units)
Table 73. China Tuberculosis Vaccine Drug Sales by Type (2018-2024) & (K Units)
Table 74. China Tuberculosis Vaccine Drug Sales by Type (2024-2029) & (K Units)
Table 75. China Tuberculosis Vaccine Drug Revenue by Type (2018-2024) & (US$ Million)
Table 76. China Tuberculosis Vaccine Drug Revenue by Type (2024-2029) & (US$ Million)
Table 77. China Tuberculosis Vaccine Drug Sales by Application (2018-2024) & (K Units)
Table 78. China Tuberculosis Vaccine Drug Sales by Application (2024-2029) & (K Units)
Table 79. China Tuberculosis Vaccine Drug Revenue by Application (2018-2024) & (US$ Million)
Table 80. China Tuberculosis Vaccine Drug Revenue by Application (2024-2029) & (US$ Million)
Table 81. Asia Tuberculosis Vaccine Drug Sales by Type (2018-2024) & (K Units)
Table 82. Asia Tuberculosis Vaccine Drug Sales by Type (2024-2029) & (K Units)
Table 83. Asia Tuberculosis Vaccine Drug Revenue by Type (2018-2024) & (US$ Million)
Table 84. Asia Tuberculosis Vaccine Drug Revenue by Type (2024-2029) & (US$ Million)
Table 85. Asia Tuberculosis Vaccine Drug Sales by Application (2018-2024) & (K Units)
Table 86. Asia Tuberculosis Vaccine Drug Sales by Application (2024-2029) & (K Units)
Table 87. Asia Tuberculosis Vaccine Drug Revenue by Application (2018-2024) & (US$ Million)
Table 88. Asia Tuberculosis Vaccine Drug Revenue by Application (2024-2029) & (US$ Million)
Table 89. Asia Tuberculosis Vaccine Drug Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 90. Asia Tuberculosis Vaccine Drug Revenue by Region (2018-2024) & (US$ Million)
Table 91. Asia Tuberculosis Vaccine Drug Revenue by Region (2024-2029) & (US$ Million)
Table 92. Asia Tuberculosis Vaccine Drug Sales by Region (2018-2024) & (K Units)
Table 93. Asia Tuberculosis Vaccine Drug Sales by Region (2024-2029) & (K Units)
Table 94. Middle East, Africa and Latin America Tuberculosis Vaccine Drug Sales by Type (2018-2024) & (K Units)
Table 95. Middle East, Africa and Latin America Tuberculosis Vaccine Drug Sales by Type (2024-2029) & (K Units)
Table 96. Middle East, Africa and Latin America Tuberculosis Vaccine Drug Revenue by Type (2018-2024) & (US$ Million)
Table 97. Middle East, Africa and Latin America Tuberculosis Vaccine Drug Revenue by Type (2024-2029) & (US$ Million)
Table 98. Middle East, Africa and Latin America Tuberculosis Vaccine Drug Sales by Application (2018-2024) & (K Units)
Table 99. Middle East, Africa and Latin America Tuberculosis Vaccine Drug Sales by Application (2024-2029) & (K Units)
Table 100. Middle East, Africa and Latin America Tuberculosis Vaccine Drug Revenue by Application (2018-2024) & (US$ Million)
Table 101. Middle East, Africa and Latin America Tuberculosis Vaccine Drug Revenue by Application (2024-2029) & (US$ Million)
Table 102. Middle East, Africa and Latin America Tuberculosis Vaccine Drug Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 103. Middle East, Africa and Latin America Tuberculosis Vaccine Drug Revenue by Country (2018-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America Tuberculosis Vaccine Drug Revenue by Country (2024-2029) & (US$ Million)
Table 105. Middle East, Africa and Latin America Tuberculosis Vaccine Drug Sales by Country (2018-2024) & (K Units)
Table 106. Middle East, Africa and Latin America Tuberculosis Vaccine Drug Sales by Country (2024-2029) & (K Units)
Table 107. Merck Company Information
Table 108. Merck Description and Major Businesses
Table 109. Merck Tuberculosis Vaccine Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 110. Merck Tuberculosis Vaccine Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. Merck Recent Developments
Table 112. Japan BCG Lab Company Information
Table 113. Japan BCG Lab Description and Major Businesses
Table 114. Japan BCG Lab Tuberculosis Vaccine Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 115. Japan BCG Lab Tuberculosis Vaccine Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Japan BCG Lab Recent Developments
Table 117. Serum Institute of India Company Information
Table 118. Serum Institute of India Description and Major Businesses
Table 119. Serum Institute of India Tuberculosis Vaccine Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 120. Serum Institute of India Tuberculosis Vaccine Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Serum Institute of India Recent Developments
Table 122. AJ Vaccines Company Information
Table 123. AJ Vaccines Description and Major Businesses
Table 124. AJ Vaccines Tuberculosis Vaccine Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 125. AJ Vaccines Tuberculosis Vaccine Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. AJ Vaccines Recent Developments
Table 127. BioFarma Company Information
Table 128. BioFarma Description and Major Businesses
Table 129. BioFarma Tuberculosis Vaccine Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 130. BioFarma Tuberculosis Vaccine Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. BioFarma Recent Developments
Table 132. GreenSignal Bio Pharma Company Information
Table 133. GreenSignal Bio Pharma Description and Major Businesses
Table 134. GreenSignal Bio Pharma Tuberculosis Vaccine Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 135. GreenSignal Bio Pharma Tuberculosis Vaccine Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. GreenSignal Bio Pharma Recent Developments
Table 137. China National Biotec Company Information
Table 138. China National Biotec Description and Major Businesses
Table 139. China National Biotec Tuberculosis Vaccine Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 140. China National Biotec Tuberculosis Vaccine Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. China National Biotec Recent Developments
Table 142. Biomed Lublin Company Information
Table 143. Biomed Lublin Description and Major Businesses
Table 144. Biomed Lublin Tuberculosis Vaccine Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 145. Biomed Lublin Tuberculosis Vaccine Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. Biomed Lublin Recent Developments
Table 147. Taj Pharmaceuticals Company Information
Table 148. Taj Pharmaceuticals Description and Major Businesses
Table 149. Taj Pharmaceuticals Tuberculosis Vaccine Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 150. Taj Pharmaceuticals Tuberculosis Vaccine Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 151. Taj Pharmaceuticals Recent Developments
Table 152. Ataulpho de Paiva Company Information
Table 153. Ataulpho de Paiva Description and Major Businesses
Table 154. Ataulpho de Paiva Tuberculosis Vaccine Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 155. Ataulpho de Paiva Tuberculosis Vaccine Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 156. Ataulpho de Paiva Recent Developments
Table 157. IVAC Company Information
Table 158. IVAC Description and Major Businesses
Table 159. IVAC Tuberculosis Vaccine Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 160. IVAC Tuberculosis Vaccine Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 161. IVAC Recent Developments
Table 162. Queen Saovabha Mem. Inst Company Information
Table 163. Queen Saovabha Mem. Inst Description and Major Businesses
Table 164. Queen Saovabha Mem. Inst Tuberculosis Vaccine Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 165. Queen Saovabha Mem. Inst Tuberculosis Vaccine Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 166. Queen Saovabha Mem. Inst Recent Developments
Table 167. Microgen Company Information
Table 168. Microgen Description and Major Businesses
Table 169. Microgen Tuberculosis Vaccine Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 170. Microgen Tuberculosis Vaccine Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 171. Microgen Recent Developments
Table 172. Key Raw Materials Lists
Table 173. Raw Materials Key Suppliers Lists
Table 174. Tuberculosis Vaccine Drug Distributors List
Table 175. Tuberculosis Vaccine Drug Customers List
Table 176. Tuberculosis Vaccine Drug Market Trends
Table 177. Tuberculosis Vaccine Drug Market Drivers
Table 178. Tuberculosis Vaccine Drug Market Challenges
Table 179. Tuberculosis Vaccine Drug Market Restraints
Table 180. Research Programs/Design for This Report
Table 181. Key Data Information from Secondary Sources
Table 182. Key Data Information from Primary Sources
List of Figures
Figure 1. Tuberculosis Vaccine Drug Product Picture
Figure 2. Global Tuberculosis Vaccine Drug Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Tuberculosis Vaccine Drug Market Share by Type in 2022 & 2029
Figure 4. Immune Vaccine Product Picture
Figure 5. Therapy Vaccine Product Picture
Figure 6. Global Tuberculosis Vaccine Drug Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 7. Global Tuberculosis Vaccine Drug Market Share by Application in 2022 & 2029
Figure 8. Self-Procurement
Figure 9. UNICEF
Figure 10. Other
Figure 11. Tuberculosis Vaccine Drug Report Years Considered
Figure 12. Global Tuberculosis Vaccine Drug Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Tuberculosis Vaccine Drug Revenue 2018-2029 (US$ Million)
Figure 14. Global Tuberculosis Vaccine Drug Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 15. Global Tuberculosis Vaccine Drug Revenue Market Share by Region (2018-2029)
Figure 16. Global Tuberculosis Vaccine Drug Sales 2018-2029 ((K Units)
Figure 17. Global Tuberculosis Vaccine Drug Sales Market Share by Region (2018-2029)
Figure 18. US & Canada Tuberculosis Vaccine Drug Sales YoY (2018-2029) & (K Units)
Figure 19. US & Canada Tuberculosis Vaccine Drug Revenue YoY (2018-2029) & (US$ Million)
Figure 20. Europe Tuberculosis Vaccine Drug Sales YoY (2018-2029) & (K Units)
Figure 21. Europe Tuberculosis Vaccine Drug Revenue YoY (2018-2029) & (US$ Million)
Figure 22. China Tuberculosis Vaccine Drug Sales YoY (2018-2029) & (K Units)
Figure 23. China Tuberculosis Vaccine Drug Revenue YoY (2018-2029) & (US$ Million)
Figure 24. Asia (excluding China) Tuberculosis Vaccine Drug Sales YoY (2018-2029) & (K Units)
Figure 25. Asia (excluding China) Tuberculosis Vaccine Drug Revenue YoY (2018-2029) & (US$ Million)
Figure 26. Middle East, Africa and Latin America Tuberculosis Vaccine Drug Sales YoY (2018-2029) & (K Units)
Figure 27. Middle East, Africa and Latin America Tuberculosis Vaccine Drug Revenue YoY (2018-2029) & (US$ Million)
Figure 28. The Tuberculosis Vaccine Drug Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 29. The Top 5 and 10 Largest Manufacturers of Tuberculosis Vaccine Drug in the World: Market Share by Tuberculosis Vaccine Drug Revenue in 2022
Figure 30. Global Tuberculosis Vaccine Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 31. Global Tuberculosis Vaccine Drug Sales Market Share by Type (2018-2029)
Figure 32. Global Tuberculosis Vaccine Drug Revenue Market Share by Type (2018-2029)
Figure 33. Global Tuberculosis Vaccine Drug Sales Market Share by Application (2018-2029)
Figure 34. Global Tuberculosis Vaccine Drug Revenue Market Share by Application (2018-2029)
Figure 35. US & Canada Tuberculosis Vaccine Drug Sales Market Share by Type (2018-2029)
Figure 36. US & Canada Tuberculosis Vaccine Drug Revenue Market Share by Type (2018-2029)
Figure 37. US & Canada Tuberculosis Vaccine Drug Sales Market Share by Application (2018-2029)
Figure 38. US & Canada Tuberculosis Vaccine Drug Revenue Market Share by Application (2018-2029)
Figure 39. US & Canada Tuberculosis Vaccine Drug Revenue Share by Country (2018-2029)
Figure 40. US & Canada Tuberculosis Vaccine Drug Sales Share by Country (2018-2029)
Figure 41. U.S. Tuberculosis Vaccine Drug Revenue (2018-2029) & (US$ Million)
Figure 42. Canada Tuberculosis Vaccine Drug Revenue (2018-2029) & (US$ Million)
Figure 43. Europe Tuberculosis Vaccine Drug Sales Market Share by Type (2018-2029)
Figure 44. Europe Tuberculosis Vaccine Drug Revenue Market Share by Type (2018-2029)
Figure 45. Europe Tuberculosis Vaccine Drug Sales Market Share by Application (2018-2029)
Figure 46. Europe Tuberculosis Vaccine Drug Revenue Market Share by Application (2018-2029)
Figure 47. Europe Tuberculosis Vaccine Drug Revenue Share by Country (2018-2029)
Figure 48. Europe Tuberculosis Vaccine Drug Sales Share by Country (2018-2029)
Figure 49. Germany Tuberculosis Vaccine Drug Revenue (2018-2029) & (US$ Million)
Figure 50. France Tuberculosis Vaccine Drug Revenue (2018-2029) & (US$ Million)
Figure 51. U.K. Tuberculosis Vaccine Drug Revenue (2018-2029) & (US$ Million)
Figure 52. Italy Tuberculosis Vaccine Drug Revenue (2018-2029) & (US$ Million)
Figure 53. Russia Tuberculosis Vaccine Drug Revenue (2018-2029) & (US$ Million)
Figure 54. China Tuberculosis Vaccine Drug Sales Market Share by Type (2018-2029)
Figure 55. China Tuberculosis Vaccine Drug Revenue Market Share by Type (2018-2029)
Figure 56. China Tuberculosis Vaccine Drug Sales Market Share by Application (2018-2029)
Figure 57. China Tuberculosis Vaccine Drug Revenue Market Share by Application (2018-2029)
Figure 58. Asia Tuberculosis Vaccine Drug Sales Market Share by Type (2018-2029)
Figure 59. Asia Tuberculosis Vaccine Drug Revenue Market Share by Type (2018-2029)
Figure 60. Asia Tuberculosis Vaccine Drug Sales Market Share by Application (2018-2029)
Figure 61. Asia Tuberculosis Vaccine Drug Revenue Market Share by Application (2018-2029)
Figure 62. Asia Tuberculosis Vaccine Drug Revenue Share by Region (2018-2029)
Figure 63. Asia Tuberculosis Vaccine Drug Sales Share by Region (2018-2029)
Figure 64. Japan Tuberculosis Vaccine Drug Revenue (2018-2029) & (US$ Million)
Figure 65. South Korea Tuberculosis Vaccine Drug Revenue (2018-2029) & (US$ Million)
Figure 66. China Taiwan Tuberculosis Vaccine Drug Revenue (2018-2029) & (US$ Million)
Figure 67. Southeast Asia Tuberculosis Vaccine Drug Revenue (2018-2029) & (US$ Million)
Figure 68. India Tuberculosis Vaccine Drug Revenue (2018-2029) & (US$ Million)
Figure 69. Middle East, Africa and Latin America Tuberculosis Vaccine Drug Sales Market Share by Type (2018-2029)
Figure 70. Middle East, Africa and Latin America Tuberculosis Vaccine Drug Revenue Market Share by Type (2018-2029)
Figure 71. Middle East, Africa and Latin America Tuberculosis Vaccine Drug Sales Market Share by Application (2018-2029)
Figure 72. Middle East, Africa and Latin America Tuberculosis Vaccine Drug Revenue Market Share by Application (2018-2029)
Figure 73. Middle East, Africa and Latin America Tuberculosis Vaccine Drug Revenue Share by Country (2018-2029)
Figure 74. Middle East, Africa and Latin America Tuberculosis Vaccine Drug Sales Share by Country (2018-2029)
Figure 75. Brazil Tuberculosis Vaccine Drug Revenue (2018-2029) & (US$ Million)
Figure 76. Mexico Tuberculosis Vaccine Drug Revenue (2018-2029) & (US$ Million)
Figure 77. Turkey Tuberculosis Vaccine Drug Revenue (2018-2029) & (US$ Million)
Figure 78. Israel Tuberculosis Vaccine Drug Revenue (2018-2029) & (US$ Million)
Figure 79. GCC Countries Tuberculosis Vaccine Drug Revenue (2018-2029) & (US$ Million)
Figure 80. Tuberculosis Vaccine Drug Value Chain
Figure 81. Tuberculosis Vaccine Drug Production Process
Figure 82. Channels of Distribution
Figure 83. Distributors Profiles
Figure 84. Bottom-up and Top-down Approaches for This Report
Figure 85. Data Triangulation
Figure 86. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries